DOS BULLETIN - Dansk Ortopædisk Selskab
DOS BULLETIN - Dansk Ortopædisk Selskab DOS BULLETIN - Dansk Ortopædisk Selskab
2010-378_DOS nr. 3 2010 29/09/10 10:08 Side 138 Preheating of cemented femoral component in THA. Prospective randomized study using RSA, DXA and clinical scores Juozas Petruskevicius, Mogens Berg Laursen, Mogens Brouw Jørgensen, Kjeld Søballe, Poul Torben Nielsen Department of Orthopedic Surgery, Orthopedic Division, Northern Denmark Region, Aalborg Hospital, University of Aarhus; Department of Orthopaedics, University Hospital of Aarhus Background: Recently published biomechanical studies showed that preheating of femoral component reduces the cement porosity on prosthesis-cement interface and enhances the interfacial shear strength. This might increase the stable fixation of stem in-vivo. Purpose: The aim of the study was to compare the migration rates, measured by radiostereometry when cementing matt- surfaced Ti femoral component preheated to 40° C with the same stem of room temperature. Secondly, we aimed to compare the periprosthetic bone changes and clinical outcomes of stems during the 2 years follow-up period. Methods: We designed a prospective randomized double-blinded study to compare the migration rates of a preheated (40°C) and non-preheated stem, using radiostereometry (RSA). The periprosthetic bone density and clinical outcomes were also registered. Eighty patients undergoing hybrid hip arthroplasty with cemented matt- surfaced Ti stem (Bi-Metric®, Biomet) were randomized to two treatment groups with 40 in each. The patients were examined using RSA, DXA, VAS and Harris Hip Score (HHS) during 2 years follow-up. Migration of femoral head centre, prosthesis tip and cement mantle’s translations were compared at 3, 12 and 24 months. Findings: Migration rates of both femoral head centre and tip was reduced for preheated stems compared with non- preheated at prosthesis-cement interface. The median femoral head subsidence for the preheated group was -0.06mm vs. -0.1mm the control group (p=0.01) at 3 months. This difference remained at the following examinations and was statistically significant at 24 months too (- 0.17mm vs. -0.24mm; p=0.04). Subsidence occurred mainly at prosthesiscement interface, while the cement mantle migrated proximally i.e. opposite to stem. We observed a correlation between male sex, increasing BMI and increased femoral head migration. DXA scans, HHS and VAS scores revealed no significant differences between the groups at any follow-up occasion. Conclusion: We concluded that stem preheating enhances in-vivo stability of cemented matt-surfaced Ti femoral component. 138
2010-378_DOS nr. 3 2010 29/09/10 10:08 Side 139 No effect of adding local infusion analgesia administrated through a catheter in pain treatment after total hip arthroplasty. A randomized double-blind and placebo-controlled clinical trial in 60 patients Kirsten Specht, Peter Revald, Hans Mandøe, John Brodersen, Svend Kreiner, Per Kjaersgaard-Andersen Department of Orthopaedics & Department of Anesthesiology, Vejle Hospital; Department and Research Unit of General Practice & Department of Biostatistics, Institute of Public Health, University of Copenhagen Background: Postoperative analgesia after primary total hip arthroplasty (THA) using opioids is associated with troublesome side effects as nausea and dizziness, as is epidural analgesic with delayed mobilization. Therefore, local infiltration analgesia (LIA) during surgery prolonged with local infusion analgesia (LINFA) into the soft tissue in the hip region through a catheter in the first postoperative days has within a short period gained a major interest in THA fast track settings. Purpose: LIA at the time of surgery is a validated treatment, the aim of this study was to investigate the additional effect of postoperative LIN- FA after THA in patients already having LIA during surgery Methods: A total of 60 consecutive patients undergoing non-cemented THA were randomized into two groups in a double- blind and controlled design. During surgery all patients received standardized pain treatment with LIA. Postoperatively patients were treated with either a solution of Ropivacain, Ketorolac and Adrenaline (LINFA group) or placebo (placebo group) administrated through a catheter to the hip 10 and 22 hours after surgery. Pain score, opioid consumption and length of stay were evaluated. Findings: After adjustment for multiple testing, there was no statistically significant post operative difference between the LINFA group and the placebo group in relation to pain and tiredness. Some evidence of a short term effect on nausea and vomiting was found. No statistically significant difference was observed in opioid consumption or length of stay between the two groups. Conclusion: We found some evidence of short term effect of LINFA on nausea and vomiting, but no evidence of an effect on postoperative 139
- Page 87 and 88: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 89 and 90: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 91 and 92: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 93 and 94: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 95 and 96: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 97 and 98: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 99 and 100: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 101 and 102: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 103 and 104: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 105 and 106: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 107 and 108: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 109 and 110: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 111 and 112: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 113 and 114: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 115 and 116: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 117 and 118: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 119 and 120: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 121 and 122: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 123 and 124: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 125 and 126: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 127 and 128: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 129 and 130: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 131 and 132: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 133 and 134: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 135 and 136: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 137: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 141 and 142: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 143 and 144: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 145 and 146: 2010-378_DOS nr. 3 2010 29/09/10 10
- Page 147: 2010-378_DOS nr. 3 2010 29/09/10 10
2010-378_<strong>DOS</strong> nr. 3 2010 29/09/10 10:08 Side 139<br />
No effect of adding local infusion analgesia administrated<br />
through a catheter in pain treatment after<br />
total hip arthroplasty. A randomized double-blind and<br />
placebo-controlled clinical trial in 60 patients<br />
Kirsten Specht, Peter Revald, Hans Mandøe, John Brodersen,<br />
Svend Kreiner, Per Kjaersgaard-Andersen<br />
Department of Orthopaedics & Department of Anesthesiology, Vejle<br />
Hospital; Department and Research Unit of General Practice &<br />
Department of Biostatistics, Institute of Public Health,<br />
University of Copenhagen<br />
Background: Postoperative analgesia after primary total hip arthroplasty<br />
(THA) using opioids is associated with troublesome side effects as<br />
nausea and dizziness, as is epidural analgesic with delayed mobilization.<br />
Therefore, local infiltration analgesia (LIA) during surgery prolonged<br />
with local infusion analgesia (LINFA) into the soft tissue in the hip<br />
region through a catheter in the first postoperative days has within a<br />
short period gained a major interest in THA fast track settings.<br />
Purpose: LIA at the time of surgery is a validated treatment, the aim of<br />
this study was to investigate the additional effect of postoperative LIN-<br />
FA after THA in patients already having LIA during surgery<br />
Methods: A total of 60 consecutive patients undergoing non-cemented<br />
THA were randomized into two groups in a double- blind and controlled<br />
design. During surgery all patients received standardized pain treatment<br />
with LIA. Postoperatively patients were treated with either a solution of<br />
Ropivacain, Ketorolac and Adrenaline (LINFA group) or placebo (placebo<br />
group) administrated through a catheter to the hip 10 and 22 hours<br />
after surgery. Pain score, opioid consumption and length of stay were<br />
evaluated.<br />
Findings: After adjustment for multiple testing, there was no statistically<br />
significant post operative difference between the LINFA group and<br />
the placebo group in relation to pain and tiredness. Some evidence of a<br />
short term effect on nausea and vomiting was found. No statistically significant<br />
difference was observed in opioid consumption or length of stay<br />
between the two groups.<br />
Conclusion: We found some evidence of short term effect of LINFA on<br />
nausea and vomiting, but no evidence of an effect on postoperative<br />
139